共 94 条
[1]
Boyer KM(1986)Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis N Engl J Med 314 1665-1669
[2]
Gotoff SP(1983)Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. III. Interruption of mother-to-infant transmission J Infect Dis 148 810-816
[3]
Boyer KM(1994)Intrapartum chemoprophylaxis of perinatal group B streptococcal infections: a critical review of randomized controlled trials Am J Obstet Gynecol 170 910-917
[4]
Gadzala CA(1995)Barriers to prevention of perinatal group B streptococcal disease Pediatr Infect Dis J 14 662-667
[5]
Kelly PD(1997)Opportunities for prevention of perinatal group B streptococcal disease: a multi-state surveillance analysis. The Neonatal Group B Streptococcal Disease Study Group Obstet Gynecol 90 901-906
[6]
Gotoff SP(1993)Comparison of prevention strategies for neonatal group B streptococcal infection. A population-based economic analysis JAMA 270 1442-1448
[7]
Ohlsson A(1999)Maternal and neonatal infection rates with three different protocols for prevention of group B streptococcal disease Am J Obstet Gynecol 180 416-422
[8]
Myhr TL(1995)Prenatal screening for group B streptococcus. I. Impact of antepartum screening on antenatal prophylaxis and intrapartum care Am J Obstet Gynecol 173 837-841
[9]
Jafari HS(1995)Prevention of neonatal group B streptococcal sepsis: is routine antenatal screening appropriate Aust NZ J Obstet Gynecol 35 120-126
[10]
Schuchat A(2000)roup B streptococcal disease in the era of intrapartum antibiotic prophylaxis N Engl J Med 342 15-20